Year archive

Simcere Pharmaceutical Group Limited — 2022 filings

All 72 regulatory filings released by Simcere Pharmaceutical Group Limited (S2P) in 2022, sourced directly from the official regulator.

72 Filings

2022 Period

2022 filings (72)

Filing	Released	Lang
CHANGE OF IMPORTANT EXECUTIVE FUNCTIONS OF DIRECTOR Regulatory Filings	2022-12-30	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0348 INJECTION (HUMANIZED TIGIT/PVRIG BISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-12-29	English
Notification Letter and Request Form to Non-registered Shareholders Regulatory Filings	2022-12-28	English
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON JANUARY 18, 2023 Regulatory Filings	2022-12-28	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2022-12-28	English
(1) CONNECTED TRANSACTIONS IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES; (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR; (3) PROPOSED APPOINTMENT OF INDEPENDENT NON-EX Regulatory Filings	2022-12-28	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0237(ANTI-PD-L1/IL-15 BISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-12-27	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2022-12-27	English
RENEWAL OF CONTINUING CONNECTED TRANSACTION AND REVISION OF ANNUAL CAPS FOR XIANBO PROPERTY LEASE AND COMPREHENSIVE SERVICES FRAMEWORK AGREEMENT Regulatory Filings	2022-12-20	English
PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR Regulatory Filings	2022-12-20	English
Revised Terms of Reference for Remuneration and Appraisal Committee Regulatory Filings	2022-12-20	English
VOLUNTARY ANNOUNCEMENT - A PHASE II/III CLINICAL STUDY OF ANTI-SARS-COV-2 DRUG CANDIDATE XIANNUOXIN (SIM0417) COMPLETE ALL PATIENTS ENROLLMENT Regulatory Filings	2022-12-18	English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-12-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-05	English
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL STUDY OF SANBEXIN SUBLINGUAL TABLETS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE ACHIEVED EXPECTED EFFICACY ENDPOINTS Regulatory Filings	2022-12-01	English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH IDORSIA FOR THE INSOMNIA DRUG DARIDOREXANT Regulatory Filings	2022-11-16	English
(1) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE; AND (3) WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND Regulatory Filings	2022-11-09	English
(1) GRANT OF AWARDS UNDER THE 2021 RSU SCHEME; AND (2) CONNECTED TRANSACTIONS IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-11-09	English
Next Day Disclosure Return Regulatory Filings	2022-11-04	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-04	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SIM0237 (ANTI-PD-L1/IL-15 BISPECIFIC ANTIBODY) ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2022-10-27	English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS Regulatory Filings	2022-10-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-06	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF INTERIM REPORT 2022 Regulatory Filings	2022-09-29	English
2022 INTERIM REPORT Regulatory Filings	2022-09-29	English
VOLUNTARY ANNOUNCEMENT-EXCLUSIVE LICENSING AGREEMENT OF SIM0278 WITH ALMIRALL S.A. FOR RIGHTS OUTSIDE GREATER CHINA Regulatory Filings	2022-09-29	English
GRANT OF AWARDS AND ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-09-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-05	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 Regulatory Filings	2022-08-31	English
FURTHER CHANGE IN USE OF PROCEEDS Regulatory Filings	2022-08-31	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2022-08-31	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE STRATEGY COMMITTEE Regulatory Filings	2022-08-31	English
DATE OF BOARD MEETING Regulatory Filings	2022-08-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-03	English
PROFIT ALERT Regulatory Filings	2022-08-01	English
CONDITIONAL MARKETING OF COSELA (TRILACICLIB HYDROCHLORIDE FOR INJECTION) IN CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-07-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-06	English
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-06-24	English
(I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 24, 2022 AND (II) PAYMENT OF FINAL DIVIDEND Regulatory Filings	2022-06-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-06	English
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-06-01	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2022-06-01	English
PROXY FORM FOR ANNUAL GENERAL MEETING Regulatory Filings	2022-06-01	English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND (IV Regulatory Filings	2022-06-01	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2022-06-01	English
Environmental, Social and Governance Report 2021 Regulatory Filings	2022-05-31	English
APPOINTMENT OF CO-CHIEF EXECUTIVE OFFICER Regulatory Filings	2022-05-25	English
Next Day Disclosure Return Regulatory Filings	2022-05-25	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-05-25	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0417 (3CL) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-05-16	English
GRANT OF AWARDS AND ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-05-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2021 Regulatory Filings	2022-04-26	English
ANNUAL REPORT 2021 Regulatory Filings	2022-04-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Regulatory Filings	2022-04-07	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2022-03-31	English
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-03-24	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-03-24	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0272 ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-03-22	English
VOLUNTARY ANNOUNCEMENT ON COOPERATION WITH LYNK PHARMACEUTICALS TO INTRODUCE SELECTIVE JAK1 INHIBITOR Regulatory Filings	2022-03-18	English
DATE OF BOARD MEETING Regulatory Filings	2022-03-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Regulatory Filings	2022-03-03	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0408 ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-02-28	English
VOLUNTARY ANNOUNCEMENT - ARBITRATION AWARD Regulatory Filings	2022-02-24	English
VOLUNTARY ANNOUNCEMENT - APPLICATION OF TRILACICLIB ON MYELOPROTECTION IN EXTENSIVE SMALL-CELL LUNG CANCER MET PRIMARY ENDPOINT IN PHASE 3 CLINICAL STUDY Regulatory Filings	2022-02-23	English
POSITIVE PROFIT ALERT Regulatory Filings	2022-02-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Regulatory Filings	2022-02-08	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL OF INVESTIGATIONAL NEW DRUG FOR SIM0235 ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2022-01-30	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2022-01-10	English
Next Day Disclosure Return Regulatory Filings	2022-01-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Regulatory Filings	2022-01-05	English